Dr Reddys Laboratories (RDY) FCF Margin (2009)

Dr Reddys Laboratories (RDY) posted quarterly FCF Margin of 15.84% for Q4 2009, down 44.36% on a QoQ basis from 28.46% in Q3 2009.

Dr Reddys Laboratories (RDY) FCF Margin (2009) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported FCF Margin for 1 consecutive years, with 15.84% the latest figure, recorded in Q4 2009.

Quarterly FCF Margin changed N/A year-over-year to 15.84% in Q4 2009, while the trailing twelve-month figure through Sep 2010 was 4.17% (down 1111.0% YoY) and the FY2026 annual result came in at 10.0%, up 415.0% from the prior year.
FCF Margin eased to 15.84% in Q4 2009 per RDY's latest filing, from 28.46% in the prior quarter.
Over the last five years, FCF Margin for RDY reached as high as 29.06% in Q2 2009 and fell as low as 15.84% in Q4 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-5.22%
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	12.86%
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-5.35%
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	46.54%
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	9.93%
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	17.73%
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-2.77%
10	Dr Reddys Laboratories	9.82 Bn	9.66 Bn	-	-

Download Data